Blocking the TLR2 pathway inhibits pro-inflammatory cytokines (IL-6, IL-8, and IL-1β) and promotes the expression of tight junction proteins, hence restoring the epidermal barrier in AD (47). The gene discussed is IL1B; the disease is Alzheimer disease.